AI Biotechnology LLC
CIK: 0001942670
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About AI Biotechnology LLC
AI Biotechnology LLC (SEC CIK 0001942670) files insider reports with the SEC as 10% Owner of OnKure Therapeutics, Inc. (OKUR) and 10% Owner of Zura Bio Ltd (ZURA).
Signal8 holds 3 ownership filings by AI Biotechnology LLC (2 Form 3, 1 Form 4), filed between May 28, 2025 and Apr 7, 2026. Those filings report 1 transaction, the latest on Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on AI Biotechnology LLC's filings is in NEW YORK, NY.
Recent filings by AI Biotechnology LLC
- Feb 26, 2026: Open-market purchase of ZURA shares (Form 4, code P).
Other insiders filing for OnKure Therapeutics, Inc. (OKUR)
- Saccomano Nicholas A, President and CEO
- Leverone Jason A., Chief Financial Officer
- Manke Isaac, Director
- Mathers Edward T, Director
- Ratcliffe Liam, Director
- Phillips Andrew John, Director